Results 81 to 90 of about 208,015 (380)

Balloon‐Expandable Versus Self‐Expanding Valves in Bicuspid Aortic Stenosis: Insights From the SWEDEHEART Registry

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter aortic valve replacement (TAVR) is increasingly used in patients with bicuspid aortic valve (BAV) stenosis, but there is limited comparative data on balloon‐expandable (BEV) versus self‐expanding valves (SEV) in this population. Aim To compare clinical and hemodynamic outcomes between BEVs and SEVs in patients with BAV
Antros Louca, Joakim Sundström, Araz Rawshani, Henrik Hagström, Magnus Settergren, Stefan James, Sasha Koul, Kristofer Skoglund, Dan Ioanes, Sebastian Völz, Anna Myredal, Oskar Angerås, Petur Petursson, Truls Råmunddal   +13 more
wiley   +1 more source

Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2019
After the success and worldwide adoption of transcatheter aortic valve replacement (TAVR), the percutaneous replacement of a diseased mitral valve (MV) rapidly became a target for investigators and industry. The rejuvenated enthusiasm of industry in this
L. Testa, A. Popolo Rubbio, M. Casenghi, G. Pero, A. Latib, F. Bedogni   +5 more
semanticscholar   +1 more source

Feasibility and Safety of Transfemoral Aortic Valve Replacement Using Local Anesthesia in the Catheterization Suite Versus General Anesthesia in the Operation Theater

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background For over a decade, transfemoral transcatheter aortic valve replacements (TF‐TAVR) have been performed at the University Hospital of Nancy. A minimalistic approach to TF‐TAVR, conducted without general anesthesia and entirely percutaneously in a catheterization suite (simplified approach), has been reported to be as safe and ...
Guillaume Abadié, Pierre Adrien Metzdorf, Giuseppe Lauria, Jeanne Varlot, Mazen Elfarra, Florian Eggenspieler, Juan‐Pablo Maureira, Batric Popovic, Edoardo Camenzind   +8 more
wiley   +1 more source

Early results after mitral valvuloplasty for pure mitral regurgitation [PDF]

, 2017
In this study we present the results of 105 consecutive patients with pure mitral regurgitation who underwent surgical treatment. In all patients mitral regurgitation was associated with mitral valve prolapse: 54 patients underwent mitral valvuloplasty ...
EGLOFF, L., GALLINO, A., HIRZEL, H. O., HURNI, R., JENNI, R., KRAYENBÜHL, H. P., ROTHLIN, M., SCHÖNBECK, M., TURINA, M.   +8 more
core  

Transapical off-pump mitral valve repair with Neochord Implantation (TOP-MINI): step-by-step guide [PDF]

, 2015
open10openColli, Andrea; Zucchetta, Fabio; Torregrossa, Gianluca; Manzan, Erica; Bizzotto, Eleonora; Besola, Laura; Bellu, Roberto; Sarais, Cristiano; Pittarello, Demetrio; Gerosa, GinoColli, Andrea; Zucchetta, Fabio; Torregrossa, Gianluca; Manzan, Erica;
Bellu, Roberto, Besola, Laura, Bizzotto, Eleonora, Colli, Andrea, Gerosa, Gino, Manzan, Erica, Pittarello, Demetrio, Sarais, Cristiano, Torregrossa, Gianluca, Zucchetta, Fabio   +9 more
core   +1 more source

Autopsy findings in cases of fatal COVID‐19 vaccine‐induced myocarditis

ESC Heart Failure, EarlyView.
Abstract COVID‐19 vaccines have been linked to myocarditis, which, in some circumstances, can be fatal. This systematic review aims to investigate potential causal links between COVID‐19 vaccines and death from myocarditis using post‐mortem analysis.
Nicolas Hulscher, Roger Hodkinson, William Makis, Peter A. McCullough   +3 more
wiley   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Short-term outcomes of repair vs. replacement for rheumatic mitral valve disease

Frontiers in Cardiovascular Medicine
BackgroundThe main types of surgery for rheumatic mitral valve disease are traditional percutaneous mitral balloon valvuloplasty (PMBV), mitral valve replacement (MVR) with removal of the original valve, and valve repair with preservation of the original
Ming Hou, Wei Zhou, Ning Zhang
doaj   +1 more source

On-pump fibrillating heart mitral valve replacement with the SAPIEN™ XT transcatheter heart valve [PDF]

, 2017
In some high-risk patients, standard mitral valve replacement can represent a challenging procedure, requiring a risky extensive decalcification of the annulus. In particular, high-risk redo patients and patients with a previously implanted transcatheter
Ferrari, Enrico, Locca, Didier, Marcucci, Carlo, Niclauss, Lars   +3 more
core